Up and down the ladder: The latest comings and goings

StatNews – View full story (behind a paywall)

Progress in the Development of CAR NK-Cell Therapies

Pharmaceutical Technology – View full story

Intellia and ONK to collaborate

MedNous – View full story

The Top European Biotech Investments in January 2022

Labiotech  – View full story

Intellia and ONK collaborate on cancer candidates

Endpoints News  – View full story

Intellia and ONK Therapeutics enter collaboration

The Pharma Letter – View full story